Georgia Capital PLC
LSE:CGEO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Georgia Capital PLC
LSE:CGEO
|
UK |
Georgia Capital PLC
Georgia Capital Plc is a holding company, which engages in the investment and development of businesses in Georgia with holdings in industries. The Company’s primary business is to develop or buy businesses, help them institutionalize their management and grow them into mature businesses. The Georgia Capital has six private businesses: a healthcare services business; a water utility business; a retail (pharmacy) business and insurance business (P&C and medical insurance); a renewable energy business, and an education business. The five businesses in its other private portfolio are Housing Development, Hospitality and Commercial Real Estate, Beverages, Auto Services and Digital Services. Georgia Capital normally seeks to monetize its investment over a 5-10 year period from an initial investment. The Company’s beverage business combines three business lines, including wine business, beer business and distribution business.
Georgia Capital Plc is a holding company, which engages in the investment and development of businesses in Georgia with holdings in industries. The Company’s primary business is to develop or buy businesses, help them institutionalize their management and grow them into mature businesses. The Georgia Capital has six private businesses: a healthcare services business; a water utility business; a retail (pharmacy) business and insurance business (P&C and medical insurance); a renewable energy business, and an education business. The five businesses in its other private portfolio are Housing Development, Hospitality and Commercial Real Estate, Beverages, Auto Services and Digital Services. Georgia Capital normally seeks to monetize its investment over a 5-10 year period from an initial investment. The Company’s beverage business combines three business lines, including wine business, beer business and distribution business.
NAV Growth: Net asset value (NAV) per share grew nearly 8% in Q3, driven by strong operating performance and share price gains in key holdings.
Outstanding Portfolio Results: Large private portfolio companies delivered nearly 30% EBITDA growth in Q3, continuing a trend of 30%+ growth over nine months.
Buybacks & Capital Return: Over 1.4 million shares bought back in Q3; progress on the GEL 700 million capital return program is ahead of schedule, with nearly half already executed.
Deleveraging: Holding company net debt reduced significantly, now targeting a debt-free position; NCC ratio improved to 5.4%, nearly three times lower year-on-year.
Segment Performance: Retail pharmacy, insurance, and healthcare businesses all reported double-digit revenue and EBITDA growth, with record high profitability and strong cash flows.
Dividend Outlook Raised: Expected portfolio company dividend inflows for the year increased to around GEL 200 million, with per share inflows up 31% due to reduced share count.
Positive Economic & Market Backdrop: Management highlighted robust macroeconomic conditions and local capital market activity, supporting continued business growth and value creation.
Buyback Remains Priority: Management confirmed that buybacks are preferred over further debt reduction at current NAV discount levels.